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The attachment of gonococci to mucosal surfaces is of primary importance in 
their interactions with the genito-urinary tract of the human host. This process 
may be, in part, mediated by pili, which are proteinaceous appendages emanating 
from the bacterial cell surface. Observations by Kellogg et al. (1) suggested that 
certain colonial morphological phenotypes are associated with virulence. Subse- 
quently, Swanson et al. (2) demonstrated that gonococci giving rise to the colonial 
phenotype associated  with virulence carry pili on  their surface.  Subsequently, 
piliated gonococci have been shown to agglutinate erythrocytes (3), and attach 
to spermatozoa (4), epithelial cells (5), and human fallopian tubes in organ culture 
(6, 7). 
Pili are filaments, 1-4 ~m in length, composed of repeating, identical subunits 
of the protein  pilin.  Pilin demonstrates a  variable apparent  molecular weight, 
depending on type, of 17,500-21,000  by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (8). Gonococcal pilins possess a single intramolecular disulfide 
bond  and  two  methionine  residues,  which  allows  for  cleavage  by  cyanogen 
bromide into three peptide fragments (CB-1, 2, and 3) (9). The CB-2 fragment 
(residues 8-92  in strain  MS11  pilin) possesses the erythrocyte-binding domain, 
as evidenced by its ability to compete with intact pili in a hemagglutination assay. 
Peptide  mapping  of CB-2  fragments  from  serologically  distinct  pilin  (strains 
MS11  and  R10)  demonstrates  homology in  this  area of the  protein  (9).  The 
complete amino acid sequence of MS 11  pilin has been obtained, as well as the 
first 59 amino acids of R10 pilin (10).  Comparison of these sequences demon- 
strates identity through amino acid 59, providing additional evidence that the 
amino-terminal half of gonococcal pilin is highly conserved. Conversely, peptide 
mapping  of  CB-3  fragments  (residues  93-159  in  MSll  pilin)  demonstrates 
significant differences between pilin types, indicating that the carboxy-terminal 
portion of the protein contains the variable domain (9). 
The  distinct  serological  heterogeneity of gonococcal pili  has  been  demon- 
strated by a number of investigators (8,  11).  Immunization of rabbits and mice 
with purified pili elicits immune responses that are strikingly type specific (8). 
Vaccination of humans with purified pili produced primarily type-specific anti- 
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bodies,  thus  limiting  the  usefulness  of this  approach  (12).  Since  the  peptide 
mapping and sequence data of pilin indicate structural homology in the amino- 
terminal half of the protein, it is remarkable that these common determinants 
escape detection by the immune system.  Because of the interest in developing 
effective vaccines for gonorrhoea, we have produced and characterized a  bank 
of mouse  monoclonal  antibodies  for  the  elucidation  of epitopes  in  the  pilin 
protein. 
Materials and Methods 
Bacterial Strains  and Media.  Neisseria gonorrhoeae strains MS 11  and R 10 have been 
maintained  in  the  laboratory for several years, and  were  isolated from patients  with 
uncomplicated, anterior urethritis. Isogenic piliated and nonpiliated clones of each strain 
were  maintained  by daily single-colony passage  on  solid  typing medium  as  described 
previously (13). 
Isolation of Pili.  Pili were isolated by a modification of the method of Brinton et al. 
(8). Briefly, piliated gonococci were inoculated onto 150 ×  15 mm solid agar plates (14) 
and grown in candle jars for 19 h. All subsequent steps were done at 4°C. Each agar plate 
was flooded with 0.15 M ethanolamine-HCl buffer, pH 9.8 and the colonies were scraped 
into a Sorvall Omnimixer cup (400 ml) (Sorvall Instruments Div., Du Pont Co., Newton, 
CT) The gonococcal suspension was blended at 2,000 rpm for  10 min.  Bacteria were 
removed  from  the  suspension  by  centrifugation  at  12,000  g  for  30  min  and  were 
reextracted with ethanolamine buffer under identical conditions. The supernates were 
pooled and centrifuged at  35,000 g  for 60  min.  Ammonium sulfate (20%) was  slowly 
added to the supernate to a final concentration of 10%. The solution was mixed for 12 h 
and then centrifuged at  12,000 g for 60 min. The pellet containing aggregated pili was 
redissolved in ethanolamine buffer and separated from the insoluble debris by centrifuga- 
tion at 17,000 g for 60 min. The solubilized pili were dialyzed exhaustively against 0.05 
M  Tris-HCI, pH  8.0,  containing 0.15  M  NaCI  (Tris-saline). The aggregated pili were 
sedimented by centrifugation at  17,000 g for 60 min, and redissolved in ethanolamine 
buffer. The solubilization-aggregation procedure was repeated twice. The purified pili 
were stored in ethanolamine buffer at 4°C. 
Preparation of Pilin Fragments.  Cyanogen bromide cleavage of R 10(Tr) pilin at methi- 
onine residues  was  performed as  described by Schoolnik et al.  (10).  CB-2  and  CB-3 
(respectively, residues 8-92 and 93-159 of the MS1 l(Tr) pilin sequence) were purified 
by reverse phase, high pressure liquid chromatography (10). Peptide TC-2 (corresponding 
to residues 31-I 11 of the MS11 (Tr) pilin sequence) was generated by tryptic hydrolysis 
of citraconylated R 10(Tr) pilin and the deblocked peptide was purified by high pressure, 
steric exclusion liquid chromatography (10). 
Synthesis ofPilin Peptide Analogues.  The peptides shown in Table I were synthesized 
by solid phase techniques (15) on a Beckman 990B peptide synthesizer (Beckman Instru- 
ments, Inc., Fullerton, CA) using commercially available t-Boc-protected amino acids and 
resins obtained from Peninsula Laboratories (Belmont, CA).  The family of coterminal 
peptides (see Fig.  1) was synthesized simultaneously by removing aliquots of resin during 
the synthesis, and deprotecting them separately. For immunological assays, each peptide 
was conjugated to bovine serum albumin through the reduced sulfhydril of the carboxy- 
terminal cysteine, using heterobifunctional coupling agents (16). 
Immunological  Methods.  Enzyme-linked  immunosorbent  assays  (ELISA)  l  (17)  were 
performed in Immulon II microtiter plates (Dynatech Laboratories, Inc., Alexandria, VA) 
sensitized overnight with pili CB-3 or CB-2, at a concentration of 1 #g/ml, TC-2 at 0.2 
#g/ml, and synthetic peptide-bovine serum albumin conjugates at 20 #g/ml, all in 0.1  M 
Tris-HC1, pH 9.8. After sensitization, the plates were washed six times with 0.9% NaCI 
and 0.05% Brij-35 (Pierce Chemical Co., Rockford, IL) (NaC1-Brij). Supernates containing 
l Abbreviations used in this paper:  BSA,  bovine serum albumin; ELISA, enzyme-linked immuno- 
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TABLE  I 
Amino Acid Sequences of the Synthetic Oligopeptides and their 
Corresponding Location in MS11 Pilin 
LPAYQDYTARAQVSEGC* 
21  35 
EGQKSAVTEYGC 
41  50 
TEYYLNHGKWPENGC 
48  60 
PPSDIKGKYVKEVEVKGC 
69  84 
* The  underlined residues do  not exist in  MS11  pilin.  The additional 
glycine and  cysteine residues were added  to  serve as  spacer and  to 
facilitate covalent attachment to carrier molecules, respectively. 
monoclonal antibodies  were added in  0.01  M  phosphate, pH  7.2,  0.15  M  NaCI,  and 
0.05% Brij-35 (PBS-Brij) and incubated 4 h at room temperature. The microtiter plates 
were again washed six times in NaCI-Brij, then incubated overnight with alkaline phos- 
phatase (Sigma Chemical Co., St.  Louis, MO)-conjugated goat anti-mouse IgG (Tago, 
Inc., Burlingame, CA) in  PBS-Brij (18). After six washings  in NaCI-Brij, p-nitrophenyl 
phosphate  (Sigma  104  phosphatase  substrate;  Sigma  Chemical  Co.)  was  added  at  a 
concentration of 1.0 mg/ml in  1 M Tris-HCI, pH 9.8,  3 mM MgCI~, and incubated at 
37°C for 1 h. The titers were defined as the reciprocal of the antibody dilution producing 
half-maximal absorbance at 405 nm. Assays were done in duplicate and the geometric 
means were reported. 
Competitive inhibition ELISA was performed in Immulon II microtiter plates sensitized 
overnight with intact pili at a concentration of 1 #g/ml in 0.1  M Tris-HCl, pH 9.8. The 
TC-2 fragment of R10  pilin  was added to dilutions of PEG-concentrated monoclonal 
supernatants in PBS-Brij and allowed to react overnight at 4 ° C. The monoclonal antibod- 
ies  were diluted to concentrations that gave 30-70%  of the maximal absorbance in a 
direct ELISA. The mixtures containing inhibitor and monoclonal antibody were added 
to the  washed,  sensitized microtiter plates and allowed to react 4  h.  Plates were then 
processed as described for the ELISA. 
Preparation  of Monoclonal  Antibodies.  BALB/c mice  were  injected with  100  #g  of 
purified gonococcal pili (strain R 10 or MS 11) in incomplete Freund's adjuvant intraperi- 
toneally.  4  wk  later,  they  were  given  an  additional  100  #g  of intact  pili  in  saline 
intraperitoneally. On day 56, the mice were examined for anti-pili antibody production 
by ELISA screening, and mice with titers >900-fold compared with preinjection sera were 
given 100 #g i.p. of pili in distilled water. 4 d later, cells were obtained from the spleens 
of three mice, fused with BALB/c NSI/I cells, and distributed to fourteen 96-well tissue 
culture plates in hypoxanthine, aminopterin, thymidine (HAT) medium (19).  14 d later, 
the supernates of each well were tested for reactivity with pili by direct ELISA. The cells 
of reactive wells  were  subcloned  by  limiting  dilution  and  propagated  in  Duibecco's 
modified Eagle's medium plus 20% fetal calf serum. The clones were frozen at -70°C 
and the supernatants containing monoclonal antibody were precipitated with PEG (final 
concentration of 15%)  and  resuspended  in  200  mM  sodium phosphate,  pH  8.0  with 
0.02% sodium azide. 
Results 
Reactivity  of Monoclonal  Antibodies  with  Intact  Pili.  Two  sets  of mice  were 
immunized, with pili from strain  MS1 1 or RIO, respectively. When the animals 
showed good serum-immune responses they were sacrificed and their spleen cells 
used in two separate fusion experiments. Hybridoma supernatants were screened EDWARDS  ET  AL.  1785 
for anti-pilin activity by ELISA using the homologous, purified pili as antigen. 
The initial screening found 66  and  44  positive wells for  R10  and  MS11  pili, 
respectively.  After  subcloning of positive  wells,  33  clones  were  isolated  that 
produced monoclonal antibodies to R 10 pilin. After additional cloning,  18  of 
the R 10 pili-reactive clones survived. Due to a technical problem, all but one of 
the MS11-reactive clones were lost, the surviving clone being 1E8/G8. The titers 
of PEG-concentrated supernatants from the 19 clones to R10 and MS11 pili are 
shown in Table II. As expected, the majority of the clones produced type-specific 
antibodies that did not cross-react with heterologous pili. The 16 R 10-reactive 
clones listed in the first two groups in Table II demonstrated significant anti- 
R 10 pili reactivity and no activity towards MS 11 pili. The third group of clones, 
however,  did demonstrate  reactivity  to  the  heterologous pili  type. Certainly, 
13D6/B 10 was only slightly reactive with MS 11 pili and was therefore a marginal 
member of this group. The clones 9B9/H5 and  1E8/G8  were equally reactive 
with either pili type and represented the clones of most interest. 
Reactivity of Monoclonal Antibodies with Linear Determinations.  To determine 
if the epitopes of these monoclonal antibodies could be localized to specific areas 
of the pilin protein, various fragments of R 10 pilin were used as antigen. The 
TABLE  II 
Immunological Reactivity of Monoclonal Antibodies 
Antibodies 
Antigens 
R10 Pili  MS11  Pili  R10 CB-3 
Group 1 
4D6/F8  14,700"  <10  6,900 
5BI2/F11  6,400  <10  9,700 
5D8/G11  3,700  <10  3,400 
5E9/7C  3,700  <10  5,600 
10A4/E9  19,400  < 10  18,100 
10C7/G9  9,700  <10  7,900 
10D9/CI 1  18,100  <10  8,200 
10F2/A5  7,350  < 10  7,900 
12F1/F5  10,400  <10  19,400 
13G7/B4  9,700  <10  12,800 
Group 2 
9H5/D5  12,800  <10  630 
9G8/D4  3,200  <10  300 
4B8/F 11  19,400  <10  300 
2D7/G 10  10,800  <10  140 
2B6/E6  5,600  < 10  140 
7A 10/G5  11,100  <10  <2 
Group 3 
9B9/H5  300  700  <2 
13Df/B 10  4,850  90  18 
1E8/G8*  9,400  7,300  <2 
* The numbers indicate reciprocal ELISA titers. 
* Clone 1E8/G8 is derived from the spleen of a mouse immunized 
MS11 pili. 
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CB-3  fragment (residues 93-159  in  MSll  pilin) of gonococcal pilin  has been 
characterized as the carboxy-terminal portion containing the source of structural 
heterogeneity. The R10 clones (group  1 of Table II) were quite reactive with 
this fragment. In these cases, the titers to R10 CB-3 and R10 pili were similar, 
suggesting their epitopes to be linear determinants, or perhaps nonlinear deter- 
minants not  destroyed by cyanogen bromide cleavage. The  second group  of 
R 10-reactive clones, however, were only minimally reactive with R 10 CB-3. This 
suggests  that  their  epitopes  reside  in  the  CB-3  fragment  but  were  partially 
destroyed upon  cleavage.  The  cross-reactive  antibodies  of group  3  did  not 
demonstrate anti-R 10 CB-3 activity. 
To probe the epitopes of the cross-reactive antibodies, a  similar analysis was 
attempted  using  the  R10  CB-2  fragment.  CB-2  from  MSll  pilin  consists  of 
residues 8-92 and is known to be homologous with the R10 pilin sequence at 
least through residue 59 (20). We therefore assumed the R10 CB-2 fragment to 
be  similar and  to  contain  most  of the cross-reactive epitopes.  Unfortunately, 
CB-2 fragments displayed anomalous behavior in ELISA. This was demonstrated 
by using a rabbit antiserum produced by immunization with purified R 10 CB-2 
in ELISA. The titer of this serum against R10 pili was 500,000, compared with 
only 50,000 against R10 CB-2. CB-2 fragments have been shown to form high 
molecular weight aggregates in aqueous solution, probably due to the hydropho- 
bic nature of residues 8-30  (21).  For this reason, a  pilin  fragment of greater 
solubility was desired. 
A solution to this problem was achieved using a similar fragment produced by 
tryptic cleavage of citraconylated pilin that cleaves proteins on the carboxyl side 
of arginine residues (22). The TC-2 fragment of MS11 pilin consists of residues 
31-111  and, on the basis of prior incomplete sequence analysis of R 10 pili, we 
made the assumption that the sequence of R10 TC-2 was similar (20). The R10 
TC-2  fragment demonstrated a  reliable antigenicity in  ELISA and the rabbit 
anti-R 10 CB-2 serum titered at 632,000. When the bank of monoclonal antibod- 
ies was tested for anti-R10  TC-2 reactivity, only 2 of 19 were positive.  These 
were 9B9/H5 and 1E8/G8, both members of the cross-reactive group 3. In each 
case their reactivities were weak:  the  maximum absorbances were 0.750  and 
0.230 for 9B9/H5 and 1E8/G8, respectively. We considered that the solid phase 
nature of the direct ELISA could interfere with antibody binding, so the R10 
TC-2  fragment  was  used as  a  competitive inhibitor  of anti-R10  pili  activity. 
Microtiter plates were sensitized with R 10 pili and reacted with various dilutions 
of supernatants from the clones in group 3 that had been pretreated with 400 
ng  of R10  TC-2.  Compared  with  the  untreated  controls,  only  the  9B9/H5 
antibodies  displayed  a  loss  of  reactivity  towards  R10  pili.  In  two  separate 
experiments, the anti-R 10 pili activity of a  1  : 1000 dilution of 9B9/H5 superna- 
tant was inhibited 66 and 62% by the R10 TC-2. Significant inhibition of 1E8/ 
G8  or  13D6/B10  was not observed. These data would localize the epitope of 
9B9/H5 in the TC-2 region of the pilin protein. 
Mapping of Epitopes with Synthetic Peptides.  To more specifically localize epi- 
topes of the cross-reactive antibodies, synthetic peptides mimicking areas of the 
CB-2 fragment of MS 11  pilin were produced. Because the complete amino acid 
sequence of MS 11  pilin is known, four peptides corresponding to residues 21- EDWARDS  ET  AL.  1787 
35,  41-50,  48-60,  and 69-84  were synthesized (Table I) and used in ELISA. 
The ability of these peptide-BSA conjugates to  bind  to  microtiter plates  was 
confirmed with a rabbit anti-MS11 CB-2 serum. Microtiter wells were sensitized 
with the peptides and reacted with the rabbit serum. Peptides 41-50 and 69-84 
were reactive at  titers >20,000.  Peptides  21-35  and 48-60  were less  reactive, 
indicating either a  marginal association with the polystyrene or a  weak immu- 
nogenicity of these areas of the pilin protein. When these peptides were used to 
screen the bank of monoclonal antibodies, all proved negative except 9B9/H5, 
whose titer with peptide 69-84 was 7,350. This was an interesting result because 
9B9/H5 was 10-fold less reactive with intact R 10 pili, suggesting that the epitope 
of 9B9/H5 is a linear determinant and is probably partially masked in the intact 
pilin protein. 
To  more finely map the epitope of the 9B9/H5  antibody, three additional 
peptides reflecting portions of peptide 69-84 were synthesized. Peptides 79-84, 
76-84,  72-84, and 69-84 were produced and conjugated to bovine serum albu- 
min. The reactivity of 9B9/H5  supernatant in ELISA with these peptide-BSA 
conjugates is shown in Fig. 1. The synthetic, 15 amino acid peptide 69-84 elicited 
a titer of 1820, whereas the 12 amino acid peptide 72-84 titered at ~ 1300. This 
decrease in  activity suggests that  the tripeptide  Pro-Pro-Ser (residues 69-71) 
contributes to the epitope of 9B9/H5  antibody.  Reactivity of the monoclonal 
antibody with peptide 76-84, an eight amino acid peptide, was greatly reduced 
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FIGURE  1.  ELISA reactivity of monoclonal antibody 9B9/H5 with synthetic peptides conju- 
gated to BSA. The amino acid sequence of each peptide appears at the top. The numbers 
represent the position in the MS11 pilin sequence. The peptide-BSA conjugates were used to 
sensitize microtiter plates,  and  dilutions  of 9B9/H5  hybridoma  supernatant  were  used  as 
primary antibody. Alkaline phosphatase-conjugated goat anti-mouse IgG diluted 1:1000 was 
used as the secondary antibody. Each point represents the mean of duplicate determinations. 1788  MONOCLONAL  ANTIBODIES  TO  GONOCOCCAL  PILl 
to a  titer of 9,  indicating that  the sequence Asp-Ile-Lys-Gly (residues 72-75) 
constitute the immunodominant area of the epitope. Since peptide 76-84 dem- 
onstrated slight reactivity, residue 76 (Lys) may represent the carboxy-terminai 
end of the epitope. The six amino acid peptide 79-84 was not reactive with 9B9/ 
H5 antibody. 
Discussion 
To summarize the ELISA results, the 19 pilin-reactive clones can be arranged 
into three groups. The first group demonstrated excellent reactivity with R 10 
pili  and  CB-3  and  were not  reactive with  MS11  pili.  These antibodies  were, 
therefore, directed towards type-specific epitopes  in  the  50  carboxy-terminal 
amino acids of RI0 pilin. The second group demonstrated similar anti-R10 pili 
reactivities as the first group, yet were only slightly reactive or not reactive with 
the CB-3  fragment of R 10 pili. Their reactivity with CB-3 was at least  10-fold 
less than that of group  1. This was most likely due to conformational changes 
upon cyanogen bromide cleavage. These antibodies could be classified as being 
directed towards type-specific, nonlinear epitopes. The third group consisted of 
the remaining three clones that demonstrated cross-reactivity between pilin types. 
Their lack of reactivity with  the CB-3  fragment indicated that  their epitopes 
probably lie in the amino-terminal half of the protein. Confirmation of this was 
achieved with 9Bg/H5,  whose reactivity was inhibited with the TC-2 fragment 
of R 10 pili. 
The propensity of animals, including humans, immunized with gonococcal pili 
to produce type-specific, anti-pili antibodies has been well documented (8,  16). 
A  study by Virji and Heckels (23) reported the production of 10  monoclonal 
antibodies reactive with pili from gonococcal strain P9 (23).  Only two of these 
antibodies demonstrated reactivity with heterologous pilin types. It was, there- 
fore, not surprising that  16  of the  19  monoclonal antibodies described in this 
study were type specific. The mechanisms whereby the pilin protein displays this 
type-specific immunodominance are unknown, although the advantages to the 
gonococcus are obvious. Since 10 of the type-specific antibodies reacted with the 
R10 CB-3  fragment (group  1),  it seems that synthetic peptides reflecting parts 
of this fragment could be used to locate these immunodominant epitopes. This 
will  become possible once the amino acid sequence of R10 pilin is completed. 
The second group of monoclonals indicated that epitopes defined by conforma- 
tional restraints are not uncommon in the pilin protein. This group of monoclonai 
antibodies may prove useful in the elucidation of tertiary structure in the carboxy- 
terminal portion of the protein. 
A major goal of this study was the description of species-specific, cross-reactive 
epitopes for vaccine research. It seems possible that a synthetic peptide encom- 
passing a species-specific epitope could serve as an effective vaccine for gonor- 
rhoea. For this reason, the cross-reactive monoclonais of group 3, especially 9B9/ 
H5 and 1E8/G8, were of great interest. 
The epitope of the immunoglobulin produced by the 9B9/H5 clone was shown 
to be a linear determinant, for the antibody was more reactive with a  15 amino 
acid peptide than intact pilin or pilin fragments containing this segment. This 
was most likely due to a partial masking of the epitope by the tertiary protein EDWARDS  ET  AL.  1789 
structure. The ELISA data with the TC-2 fragment of R10 pilin supports this 
idea,  since  TC-2  was  a  more  effective  antigen  for  the  9Bg/H5  antibody  in 
solution (competitive inhibition ELISA) than when bound to polystyrene (direct 
ELISA).  The  flexibility  of the  TC-2  fragment  in  solution  might be  greater, 
leading to an increased exposure of buried epitopes. 
The use of synthetic peptides homologous to the amino acid sequence of MS 11 
pilin enabled the fine mapping of the 9B9/H5 epitope. Initially, this epitope was 
localized  to  the  area  of the  protein  near  amino acids  69-84.  This  synthetic 
peptide was an effective antigen alone or as a  BSA conjugate in direct ELISA. 
The  reactivity  of 9Bg/H5  antibody  with  shorter  peptides  indicated  that  the 
epitope must lie between amino acids 69 and 76, with residues 72-75 composing 
the primary structural entity of the epitope. It is possible that the epitope extends 
beyond the amino-terminal side of residue 69, but this seems unlikely due to size 
restrictions  for  a  linear  epitope,  ~6  residues  (24).  The  fine  mapping of this 
epitope using peptides that mimic known sequences demonstrated the utility of 
this approach. 
The 1E8/G8 antibody differs from 9B9/H5 in two significant properties. First, 
1E8/G8  demonstrates excellent reactivity  with intact  gonococcal pili.  Second, 
the epitope responsible seems nonlinear, since none of the peptide fragments or 
synthetic peptides were strongly antigenic for the  1E8/G8 antibody. The weak 
reactivity of this monoclonal antibody with the R 10 TC-2 fragment suggests that 
the epitope is located in this area of the protein. Conformational changes of the 
TC-2 fragment could explain the loss of the epitope. The 1E8/G8 antibody has 
proven to be  most useful as an immunological reagent.  Because of its strong 
reactivity with gonococcal pill, it has been used as a  probe for pili in Western 
blotting of electrophoretically separated  pilin and  as  the primary antibody in 
indirect immunofluorescence of intact organisms. The fact that  1E8/G8 reacts 
with monomeric pilin in Western blots indicates that its epitope is not destroyed 
by SDS and that it is not intermolecular. The fact that this antibody cross-reacts 
so well  with  intact  pili  or pilin  makes elucidation  of its epitope desirable  for 
vaccine research. 
Summary 
A bank of mouse monoclonal antibodies has been produced with reactivity to 
gonococcal pili to investigate epitopes of the pilus structural protein, pilin.  Pili 
of Neisseria gonorrhoeae strains R 10 and MS 11 were used as immunogens to elicit 
19 monoclonal antibodies reactive with the homologous pili type in ELISA. Of 
the  19  antibodies,  16  demonstrated  type-specific reactivity and  3  were  cross- 
reactive with heterologous pili.  Reactivity of the antibodies with the carboxy- 
terminal, cyanogen bromide fragment (CB-3) of R 10 pilin allowed their classifi- 
cation into three groups. The first group (10 antibodies) were R 10 specific and 
equally reactive with the R10 CB-3 fragment. The second group (6) were also 
type specific but  demonstrated poor  reactivity  with the  CB-3  fragment.  This 
suggested that the epitopes of the first group are linear, and those of the second 
group, nonlinear. The third group (3), consisting of the cross-reactive antibodies, 
were not reactive with the CB,3  fragment.  Two of the antibodies in group 3 
were examined in detail to localize their epitopes. The epitope of one, 9Bg/H5, 1790  MONOCLONAL  ANTIBODIES  TO  GONOCOCCAL  PILl 
was shown to be a linear determinant. This antibody was reactive with a fragment 
of MS11 pilin (residues 31-111) and to a synthetic peptide representing residues 
69-84 in MS11 pilin. The epitope was more finely mapped, with shorter synthetic 
peptides conjugated to bovine serum albumin,  to an eight amino acid segment 
(residues 69-76). The epitope of 1E8/G8, a  strongly reactive antibody, proved 
elusive  to  this  type  of analysis  and  probably  results  from  conformational  re- 
straints.  The  significance  of  species-specific  epitopes  in  the  pilin  protein  is 
discussed. 
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